Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Current status of carbapenemases in Latin America

  • Juan J. Maya
  • , Sory J. Ruiz
  • , Victor M. Blanco
  • , Eduardo Gotuzzo
  • , Manuel Guzman-Blanco
  • , Jaime Labarca
  • , Mauro Salles
  • , John P. Quinn
  • , Maria V. Villegas
  • Centro Internacional de Entrenamiento e Investigaciones Medicas
  • Hospital Nacional Cayetano Heredia
  • Hospital Vargas de Caracas y Centro Medico de Caracas
  • Pontificia Universidad Católica de Chile
  • Santa Casa de São Paulo School of Medicine
  • AstraZeneca

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

29 Citas (Scopus)

Resumen

Enterobacteriaceae and non fermenting Gram-negative bacilli have become a threat to public health, in part due to their resistance to multiple antibiotic classes, which ultimately have led to an increase in morbidity and mortality. β-lactams are currently the mainstay for combating infections caused by these microorganisms, and β-lactamases are the major mechanism of resistance to this class of antibiotics. Within the β-lactamases, carbapenemases pose one of the gravest threats, as they compromise one of our most potent lines of defense, the carbapenems. Carbapenemases are being continuously identified worldwide; and in Latin America, numerous members of these enzymes have been reported. In this region, the high incidence of reports implies that carbapenemases have become a menace and that they are an issue that must be carefully studied and analyzed.

Idioma originalInglés
Páginas (desde-hasta)657-667
Número de páginas11
PublicaciónExpert Review of Anti-Infective Therapy
Volumen11
N.º7
DOI
EstadoPublicada - jul. 2013
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Current status of carbapenemases in Latin America'. En conjunto forman una huella única.

Citar esto